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Oral squamous cell carcinoma (OSCC) is one of the most common malignances. In epithelial-mesenchymal transition (EMT), epithelial cells switch to mesenchymal-
like cells exhibiting high mobility. This migratory phenotype is significant during tumor 
invasion and metastasis. Objective: The aim of this study is to evaluate the expression of 
the EMT markers E-cadherin, N-cadherin and vimentin in OSCC. Material and Methods: 
Immunohistochemical detection of E-cadherin, N-cadherin and vimentin was performed on 
20 OSCC samples. Differences in the expression of each protein at the invasive front (IF) 
and in the central/superficial areas (CSA) of the tumor were assessed. Differences in the 
expression of each protein at the IF of both histologically high- and low-invasive OSCCs were 
evaluated. Associations among expression of proteins at the IF were assessed. Correlations 
between the expression levels of each protein at the IF and the tumor stage and clinical 
nodal status were also evaluated. Results: Reduced expression of E-cadherin was detected 
in 15 samples (75%). E-cadherin expression was reduced at the IF when compared to the 
CSA and in high-invasive tumors when compared to low-invasive tumors. All samples were 
negative for N-cadherin, even though one sample showed an inconspicuous expression. 
Positive expression of vimentin was observed in 6 samples (30%). Nevertheless, there was 
no difference in vimentin expression between the IF and the CSA regions or between the 
low- and high-invasive tumors. Furthermore, no association was observed among protein 
expression levels at the IF. Finally, no correlations were observed between each protein’s 
expression levels and tumor stage or clinical nodal status. Conclusions: Reduced E-cadherin 
expression at the IF and its association with histological invasiveness suggest that this 
protein is a noteworthy EMT marker in OSCC. Although vimentin was also detected as an 
EMT marker, its expression was neither limited to the IF nor was it related to histological 
invasiveness.
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INTRODUCTION
Oral squamous cell carcinoma (OSCC) is one 
of the most common malignances worldwide6, 
and its most significant risk factors are the use of 
tobacco and alcohol22. This tumor mostly affects 
men over 40 years old and frequently occurs in the 
lower lip, tongue, floor of the mouth, soft palate, 
and the gingival/alveolar ridge12. The deepest and 
most invasive areas of this tumor are histologically 
located at the invasive front (IF), which has been 
identified as the area chiefly responsible for its 
clinical behavior3,17.
The epithelial-mesenchymal transition (EMT) is a 
biological event in which epithelial cells lose many of 
their phenotypic features and gain extra properties 
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typical of mesenchymal cells. One of the hallmark 
signs of EMT is the transformation of cohesive and 
polarized epithelial cells into mesenchymal-like cells 
that exhibit no polarization and high mobility. This 
migratory phenotype is the hallmark of an important 
type of EMT that involves neoplastic cells originating 
from epithelial malignant neoplasms during tumor 
invasion and metastasis4,7,21,25,29.
The transmembrane glycoprotein E-cadherin 
is the major molecule responsible for cell-cell 
adhesion in epithelial tissues and plays an essential 
role in the establishment and maintenance of 
its polarity and structural integrity2,24. A loss of 
E-cadherin expression increases the mobility of 
epithelial cells and its ability for local invasion, and 
has been used as a marker of EMT during tumor 
progression2,7,21,24,29.
N-cadherin is a member of the cadherin family 
and is located mainly in neural tissue and striated 
muscle2,24. Although epithelial cells do not express 
this molecule, a gain in N-cadherin expression 
is usually associated with loss of E-cadherin 
expression during an EMT phenomenon called the 
“cadherin switch”, which increases the mobility of 
neoplastic epithelial cells and their ability to invade 
locally9.
Vimentin is a main component of the intermediate 
filament family of proteins, and it is expressed in 
mesenchymal cells such as fibroblasts, endothelial 
cells, hematopoietic cells and glial cells20. This 
protein is not expressed in normal epithelial cells 
and has been identified as a marker of EMT in 
epithelial malignant tumors. It is also associated 
with an invasive tumor cell phenotype20,29.
The aim of this study is to evaluate the 
expression of the EMT markers E-cadherin, 
N-cadherin and vimentin in OSCC. Differences in the 
expression of each protein at the IF and in central/
superficial areas (CSA) of the tumor were assessed. 
Differences in the expression of each protein at the 
IF of both high- and low-invasive OSCCs were also 
evaluated. Moreover, associations among protein 
expression levels at the IF were evaluated. Finally, 
correlations between the expression levels of each 
protein at the IF and the tumor stage and the clinical 
nodal status were also assessed.
MATERIAL AND METHODS
Tissue samples
This study was approved by the local ethics 
committee (CAAE – 0174.0.213.000-10).
A total of 20 OSCC samples were obtained 
from archival formalin-fixed paraffin-embedded 
specimens and were evaluated. Out of the 20 OSCC 
samples, 18 (90%) were from male and 2 (10%) 
from female individuals. The age of the patients 
ranged from 34 to 73 years (mean age: 54.2 years). 
Out of the 20 tumors, 7 were sited at the tongue, 
4 at the lower lip, 4 at the floor of the mouth, 2 at 
the retromolar triangle, 2 at the soft palate and 1 at 
the alveolar ridge. Tumors were staged by the TNM 
classification, as follows: 5 stage I tumors, 5 stage 
II tumors, 4 stage III tumors and 6 stage IV tumors. 
Based on the N stage of the TNM, the clinical 
nodal status of the tumors was also categorized as 
follows: absence of clinical nodal metastasis (N0; 
13 tumors) or presence of clinical nodal metastasis 
(N1, N2 or N3; 7 tumors).
The following inclusion criteria were applied: 
1) OSCC samples were obtained by total surgical 
resection; and 2) samples were limited to OSCCs in 
which the CSA and the IF could be clearly identified. 
Evaluation of OSCC patterns of invasion
The patterns of invasion of OSSC samples were 
examined in hematoxylin and eosin stained sections 
according to the method of Bryne, et al.3 (1992). 
Each pattern of invasion was classified as one of 
the following: grade 1 - pushing, well delineated 
infiltrating borders; grade 2 - infiltrating, solid 
cords, bands and/or strands; grade 3 - small groups 
or cords of infiltrating cells (n>15 cells); and grade 
4 - marked and widespread cellular dissociation in 
small groups and/or in single cells (n<15 cells). 
The samples were subsequently classified as either 
low-invasive OSCC (pattern of invasion grades 1, 
2 or 3) or high-invasive OSCC (pattern of invasion 
grade 4), as previously reported23.
Immunohistochemistry
For the immunohistochemical detection of 
E-cadherin, N-cadherin and vimentin, 4 µm sections 
obtained from the paraffin-embedded samples were 
used. Tissue sections were dewaxed with xylenes, 
hydrated with graded alcohols, and treated with 
0.6% H2O2 to eliminate endogenous peroxidase 
activity. Antigen retrieval for E-cadherin and 
N-cadherin was performed by heating the samples 
in a 0.01 M citrate buffer (pH 6.0) for 30 minutes. 
Antigen retrieval for vimentin was performed by 
heating the samples in a Tris/EDTA buffer (pH 9.0) 
for 30 minutes. Subsequently, one of the following 
primary antibodies was used: 1) anti-E-cadherin 
monoclonal antibody (clone 36B5, diluted 1:50, 
incubated overnight at 4°C; Leica Biosystems, 
Newcastle, UK); 2) anti-N-cadherin monoclonal 
antibody (clone IAR06, diluted 1:50, incubated 
overnight at 4°C; Leica Biosystems, Newcastle, 
UK); or 3) anti-vimentin monoclonal antibody (clone 
SRL33, diluted 1:200, incubated overnight at 4°C; 
Leica Biosystems, Newcastle, UK). Afterward, one 
of the following immunohistochemical visualization 
systems was used (according to the manufacturer’s 
instructions): 1) For E-cadherin and vimentin 
detection, the LSAB+ kit (Dako Corporation, 
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Carpinteria, California, USA); 2) For N-cadherin 
detection, the REVEAL Biotin-Free Detection 
System (Spring Bioscience Corporation, Pleasanton, 
California, USA). The reactive products were 
visualized by immersing the sections in 0.03% 
diaminobenzidine solution containing 2 mM H2O2 for 
3 min. The sections were then counterstained with 
Mayer’s hematoxylin, dehydrated, and mounted.
Samples of oral fibrous hyperplasia were used 
as positive controls for E-cadherin and vimentin 
staining. In addition, samples of normal cardiac 
striated muscle and normal testis were used as 
positive controls for N-cadherin. Furthermore, 
immunostaining of morphologically normal oral 
mucosa epithelium adjacent to the tumor, peripheral 
nerve bundles in tumor stroma and the tumor’s 
connective tissue mesenchymal cells were used as 
internal positive controls for E-cadherin, N-cadherin 
and vimentin, respectively. Negative controls were 
performed via omission of the primary antibody.
Scoring of immunostaining results
The expression of E-cadherin, N-cadherin 
and vimentin in each sample was independently 
assessed at the IF and at the CSA.
The expression of E-cadherin was classified 
as follows14: 1) “preserved”: membranous 
immunostaining in more than 50% of the epithelial 
tumor cells; or 2) “reduced”: membranous 
immunostaining in 50% or less of the epithelial 
tumor cells.
The expression of N-cadherin was classified 
as follows19: 1) “negative”: cytoplasmic or 
membranous immunostaining in less than 5% of the 
epithelial tumor cells; or 2) “positive”: cytoplasmic 
or membranous immunostaining in 5% or more of 
the epithelial tumor cells.
The expression of vimentin was classified as 
follows27: 1) “negative”: cytoplasmic immunostaining 
in less than 10% of the epithelial tumor cells; or 2) 
“positive”: cytoplasmic immunostaining in 10% or 
more of the epithelial tumor cells. 
This analysis was performed independently by 
two authors. Doubtful cases were reanalyzed, and 
a consensus score was agreed upon.
Statistical analysis
Differences in the expression levels of each 
protein at the IF and the CSA of the OSCC were 
analyzed using the McNemar test. Fischer’s exact 
test was used to assess differences in the expression 
levels of each protein at the IF for both high- and 
low-invasive OSCC. Fischer’s exact test was used 
to evaluate associations between the expression 
levels of each protein at the IF. The Spearman test 
was employed to assess correlations between the 
expression levels of each protein at the IF and the 
tumor stage (TNM classification). Finally, Fischer’s 
E-cadherin expression n p-value*
Preserved at the CSA / Preserved at the IF 5 (25%) <0.05
Preserved at the CSA / Reduced at the IF 11 (55%)
Reduced at the CSA / Preserved at the IF 0 (0%)
Reduced at the CSA / Reduced at the IF 4 (20%)
Total 20 (100%)
N-cadherin expression n p-value*
Negative at the CSA / Negative at the IF 20 (100%) n.s.
Negative at the CSA / Positive at the IF 0 (0%)
Positive at the CSA / Negative at the IF 0 (0%)
Positive at the CSA / Positive at the IF 0 (0%)
Total 20 (100%)
Vimentin expression n p-value*
Negative at the CSA / Negative at the IF 14 (70%) n.s.
Negative at the CSA / Positive at the IF 3 (15%)
Positive at the CSA / Negative at the IF 0 (0%)
Positive at the CSA / Positive at the IF 3 (15%)
Total 20 (100%)
*p-values were obtained by the McNemar test
n.s. - not significant
Table 1- E-cadherin, N-cadherin and vimentin expression at the invasive front (IF) and in the central/superficial areas 
(CSA) of oral squamous cell carcinoma
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exact test was also used to evaluate associations 
between the expression levels of each protein at 
the IF and the clinical nodal status. The level of 
significance was set at 5%. All statistical analysis 
was performed using GraphPad Prism software 
(GraphPad Software, San Diego, California, USA).
RESULTS
Regarding the pattern of invasion, the 20 
OSCC samples were initially classified as grade 
1 (1 sample), grade 2 (1 sample), grade 3 (5 
samples) and grade 4 (13 samples). Afterward, 
these scores were dichotomized as 7 low-invasive 
OSCCs (pattern of invasion grades 1, 2 or 3) and 13 
high-invasive OSCCs (pattern of invasion grade 4).
The results of the E-cadherin expression are 
illustrated in both Table 1 and Figure 1. Out 
of the 20 OSCC samples, 15 (75%) exhibited 
reduced expression of E-cadherin in one of the two 
evaluated regions (CSA or IF). Preserved E-cadherin 
expression at both the CSA and the IF was 
observed in 5 (25%) samples. Preserved E-cadherin 
expression at the CSA and reduced expression at 
the IF were found in 11 (55%) samples. Reduced 
E-cadherin expression at both the CSA and the IF 
of OSCCs was seen in 4 (20%) samples. Samples 
exhibiting reduced E-cadherin expression at the 
CSA and preserved expression at the IF were not 
observed. The E-cadherin expression was reduced 
at the IF when compared to expression levels at 
the CSA (p<0.05).
The N-cadherin expression is illustrated in both 
Table 1 and Figure 2. N-cadherin expression was 
negative in all 20 of the OSCC samples at both 
the IF and the CSA, and no statistically significant 
difference was observed (p>0.05). It is important 
to inform that one OSCC sample showed an 
inconspicuous N-cadherin expression. These few 
tumor cells expressing N-cadherin were located 
in a minor area at the IF of a high-invasive tumor 
(pattern of invasion grade 4). Nevertheless, 
even this sample was classified as negative for 
N-cadherin, since less than 5% of the epithelial 
tumor cells in this area showed immunostaining.
Vimentin expression results are demonstrated 
in both Table 1 and Figure 3. Out of the 20 OSCC 
samples, 6 (30%) exhibited positive vimentin 
expression in one of the two evaluated regions (CSA 
or IF). Negative vimentin expression at both the 
CSA and the IF was observed in 14 (70%) samples. 
Negative vimentin expression at the CSA and 
positive expression at the IF was seen in 3 (15%) 
samples. Positive vimentin expression at both the 
CSA and the IF was found in 3 (15%) samples. No 
samples exhibited positive vimentin expression 
Figure 1- Immunohistochemical reactivity for E-cadherin in oral squamous cell carcinoma (OSCC). A: OSCC displaying 
preserved E-cadherin expression at the CSA (X400); B: OSCC exhibiting reduced E-cadherin expression at the IF (X400); 
C and D: OSCC exhibiting preserved E-cadherin expression at the morphologically normal oral mucosa epithelium adjacent 
to the tumor (C, X40), preserved E-cadherin expression at the CSA (C, X40) and reduced E-cadherin expression at the IF 
(C, X40; D, X400)
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at the CSA and negative expression at the IF. No 
statistically significant difference was observed 
for vimentin expression when the IF region was 
compared to the CSA region (p>0.05).
The comparison of each protein expression level 
at the IF for both high- and low-invasive OSCC is 
illustrated in Table 2. The E-cadherin expression 
was reduced at the IF of high-invasive OSCC 
when compared to low-invasive OSCCs (p<0.05). 
Nevertheless, no difference in either vimentin 
expression at the IF or N-cadherin expression at 
the IF was observed for low- and high-invasive 
OSCCs (p>0.05).
Results of the association between the expression 
levels of each protein at the IF are illustrated in 
Table 3. As shown, no association was observed 
(p>0.05).
Finally, no correlations were observed between 
the expression levels of each protein at the IF and 
the tumor stage (TNM classification) (p>0.05) or 
the clinical nodal status (based on the N stage of 
the TNM) (p>0.05).
DISCUSSION
EMT is an important biological event in which 
cohesive and polarized epithelial cells switch to 
mesenchymal-like cells exhibiting no polarization 
Figure 2- Immunohistochemical reactivity for N-cadherin in oral squamous cell carcinoma (OSCC), normal cardiac striated 
muscle and normal testis. In OSCC, immunostaining of peripheral nerve bundles in the tumor stroma (marked with asterisk) 
were used as internal positive controls for N-cadherin. A and B: OSCC exhibiting negative N-cadherin expression (A, X200; 
B, X400); C and D: OSCC showing inconspicuous N-cadherin expression (C, X400; D, X400); E: normal cardiac striated 
muscle (N-cadherin positive control) exhibiting positive N-cadherin immunostaining in the intercalated disc (E, X400); F: 
normal testis (N-cadherin positive control) showing cytoplasmic and membranous N-cadherin immunostaining (E, X400)
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and high mobility. This acquired migratory 
phenotype is important, particularly during tumor 
invasion and metastasis4,7,21,25,29. The altered 
expression of EMT markers such as E-cadherin, 
N-cadherin and vimentin have recently been studied 
in various malignant epithelial tumors7,29.  Because 
the IF has been identified as the region chiefly 
responsible for the clinical behavior of OSCC3,17, 
the evaluation of these EMT markers in this tumor 
area is noteworthy.
This study revealed a heterogeneous loss 
of E-cadherin expression in OSCCs, as reduced 
expression of this protein was observed in 15 
of the samples (75%). Reduced expression 
of E-cadherin has been previously reported in 
OSCCs1,5,8,13,14,16,19,26-28. E-cadherin is the main 
adhesion molecule in epithelial tissue and is 
essential for the establishment and maintenance 
of epithelial structural integrity2,24. Several 
mechanisms for inactivating E-cadherin protein or 
the E-cadherin gene CDH1 have been described in 
human malignant tumors: hereditary and somatic 
mutations, promoter hypermethylation, abnormal 
protein processing, and induction of transcriptional 
repressors2. Because the loss of E-cadherin 
expression increases the mobility of epithelial 
cells and its ability to infiltrate locally, it has been 
used as an EMT marker during tumor invasion and 
metastasis2,7,24,29. Loss of E-cadherin expression 
in OSCCs has been associated with a reduction 
Figure 3- Immunohistochemical reactivity for vimentin in oral squamous cell carcinoma (OSCC). Immunostaining of the 
tumor’s connective tissue mesenchymal cells was used as an internal positive control. A and B: OSCC showing negative 
vimentin expression (A, X400; B, X400); C and D: OSCC displaying positive vimentin expression at the IF (E, X400; F, 
X400); E: OSCC exhibiting negative vimentin expression at the CSA (E, X400). This is the same sample of the Figure 1A 
(preserved E-cadherin expression); F: OSCC displaying positive vimentin expression at the IF (E, X400). This is the same 
sample of the Figure 1D (reduced E-cadherin expression)
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in disease-free rates1,5, a higher prevalence of 
lymph node metastasis19,27 and a lower survival 
rate1,5,13,27,28, although no association with prognosis 
has been reported14,16,26.
Reduced E-cadherin expression was observed 
at the IF when compared to the CSA of the tumor 
(p<0.05). Similar results have been previously 
reported19,27,28. These findings advocate that the loss 
of E-cadherin expression occurs mainly at the IF, 
suggesting that tumor cells in this important area 
could detach and invade local tissue more easily and 
thus increase the potential for metastasis.
E-cadherin expression was reduced at the IF 
of high-invasive OSCCs when compared to low-
invasive OSCCs (p<0.05). This result suggests that 
its reduction at the IF may be associated with a high 
histological dissociation pattern of the tumor cells. 
It is important to note that the histological pattern 
of invasion, which is used to categorize the tumors 
as low- or high-invasive, is an important histological 
parameter that reflects the invasive features of 
the tumor3,17 and has been used as a prognostic 
marker for OSCC17. Diniz-Freitas, et al.5 (2006) 
demonstrated that weak or absent E-cadherin 
expression in OSCC was associated with a more 
invasive histological pattern. Moreover, Wang, et 
al.28 (2009) reported that OSCC exhibiting loss of 
E-cadherin expression at the IF also showed the 
highest IF histological grading scores. In contrast, 
Mahomed, et al.14 (2007) did not observe an 
association between E-cadherin expression at the 
IF and the IF grading score in OSCC samples.
All OSCC samples were negative for N-cadherin, 
despite the fact that one sample showed an 
inconspicuous expression. Although some 
studies have described very limited expression 
of N-cadherin in OSCC, it was not correlated with 
clinicopathological parameters8,26; however, an 
association between N-cadherin expression in 
OSCC and lymph node metastasis was reported30. 
These divergent results for N-cadherin expression 
obtained during the present study and previous 
Low-invasive OSCC High-invasive OSCC p-value *
E-cadherin
Preserved 4 (20%) 1 (5%) <0.05
Reduced 3 (15%) 12 (60%)
N-cadherin
Negative 7 (35%) 13 (65%) n.s.
Positive 0 (0%) 0 (0%)
Vimentin
Negative 6 (30%) 8 (40%) n.s.
Positive 1 (5%) 5 (25%)
Table 2- E-cadherin, N-cadherin and vimentin expression at the invasive front (IF) of low- and high-invasive oral squamous 
cell carcinoma
* p-values were obtained by Fischer’s Exact test
n.s. - not significant
OSCC=oral squamous cell carcinoma
Vimentin (negative) Vimentin (positive) p-value*
E-cadherin (preserved) 5 (25%) 0 (0%) n.s.
E-cadherin (reduced) 9 (45%) 6 (30%)
Vimentin (negative) Vimentin (positive) p-value*
N-cadherin (negative) 14 (70%) 6 (30%) n.s.
N-cadherin (positive) 0 (0%) 0 (0%)
N-cadherin (negative) N-cadherin (positive) p-value*
E-cadherin (preserved) 5 (25%) 0 (0%) n.s.
E-cadherin (reduced) 15 (75%) 0 (0%)
* p-values were obtained by Fischer’s Exact test
n.s. - not significant
Table 3- E-cadherin, N-cadherin and vimentin expression at the invasive front (IF) of oral squamous cell carcinoma
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reports that have evaluated OSCC  could be 
explained by discrepancies in sample processing, 
the use of different primary antibodies, variability 
in immunohistochemical techniques or even the 
immunostaining evaluation employed in each study. 
It is important to state that in the present study, 
N-cadherin expression was rigorously assessed 
using appropriate external and internal positive 
controls in selected OSCC samples that were 
subjected to the criteria outlined in the Material 
and Methods section.
As an obvious consequence of the absence 
of N-cadherin expression, the present study 
demonstrates no association between E-cadherin 
and N-cadherin expression at the IF. Therefore, no 
occurrence of an E-cadherin to N-cadherin switch 
was observed in the OSCC samples evaluated in this 
study. The concomitant loss of E-cadherin and gain 
of N-cadherin expression (cadherin switch) has been 
recently reported in malignant epithelial tumors 
including head and neck30 and oral19 squamous 
cell carcinoma. This phenomenon, which increases 
both the mobility and invasiveness of neoplastic 
epithelial cells, has also been used as an indicator 
of the occurrence of EMT19. Nevertheless, unrelated 
loss of E-cadherin and gain of N-cadherin, not giving 
rise to cadherin switch, has also been reported in 
OSCC8,26. In fact, in vitro studies have demonstrated 
that overexpression of Slug (a member of the 
Snail family of zinc finger transcription factors) 
induces an E- to N-cadherin switch in oral11 and 
head and neck30 squamous cell carcinoma cell lines. 
However, as demonstrated by Hashimoto, et al.8 
(2012), OSCC cell lines expressing N-cadherin in 
vitro produce xenotransplantated mouse tongue 
tumors showing an insignificant expression of 
N-cadherin in vivo. According to these authors, the 
environments surrounding OSCC cells largely affect 
the N-cadherin expression8.
A heterogeneous vimentin expression was 
observed in the present study, since positive 
expression of this EMT marker was observed in 6 
samples (30%). Similar results have been previously 
reported in OSCC13,27. Vimentin is an intermediate 
filament normally expressed by cells presenting 
a mesenchymal phenotype20. Its expression by 
epithelial malignant tumors cells is associated 
with high invasiveness and has been considered 
a reliable EMT marker20,29. In vitro studies have 
shown that inhibition of vimentin expression results 
in reversal of the mesenchymal phenotype and 
reduction of migratory and invasive capability of 
OSCC cell lines18. In fact, vimentin expression has 
been associated with higher prevalence of lymph 
node metastasis in esophageal10 as well as in head 
and neck squamous cell carcinoma15. Moreover, 
Liu, et al.13 (2010)  reported a higher prevalence 
of recurrences and a lesser survival time in OSCC 
showing positive vimentin expression.
No significant difference in vimentin expression 
was observed between the IF and the CSA regions 
(p>0.05); however, negative vimentin expression 
at the CSA and positive expression at the IF were 
observed in 3 (15%) samples, and no samples 
exhibited positive vimentin expression at the CSA 
and negative expression at the IF. This finding 
suggests that the expression of this EMT marker 
in OSCCs is not limited to the IF cells. In contrast, 
Wang, et al.27 (2011) reported increased expression 
of vimentin at the IF of OSCCs when compared to 
the CSA of the tumor.
No difference in vimentin expression at the 
IF was observed between low- and high-invasive 
OSCC (p>0.05). Liu, et al.13 (2010) also reported 
no association between vimentin expression at the 
IF and the histological pattern of invasion of OSCC. 
These findings suggest that vimentin expression is 
not related to the histological invasiveness of the 
OSCC. Nevertheless, association between higher 
histological invasiveness and positive vimentin 
expression was observed in head and neck 
squamous cell carcinoma15.
No association was observed between E-cadherin, 
N-cadherin and vimentin expression at the IF 
(p>0.05). This result suggests that although EMT 
markers should mediate tumor progression21, the 
expression of different EMT markers in OSCC is not 
necessarily associated. As previously discussed, 
the concomitant loss of E-cadherin and gain of 
N-cadherin (cadherin switch) was found in head and 
neck30 and oral19 squamous cell carcinoma; however, 
unrelated loss of E-cadherin and gain of N-cadherin 
in OSCC was also reported8,26. For E-cadherin and 
vimentin, it is important to note that, although no 
significant difference was observed, all samples 
that exhibited positive expression of vimentin at the 
IF also displayed reduced E-cadherin expression. 
In fact, Liu, et al.13 (2010) reported a correlation 
between loss of E-cadherin expression and gain of 
vimentin expression at the IF in OSCC.
No correlations were observed between the 
expression levels of each protein at the IF and 
the tumor stage (p>0.05) or the clinical nodal 
status (p>0.05). As previously discussed, loss 
of E-cadherin, gain of vimentin and gain of 
N-cadherin in OSCC have been associated with a 
higher occurrence of lymph node metastasis19,27,30 
and a lower survival rate1,5,13,27,28, even though 
no association with prognosis has also been 
reported8,14,16,26. In fact, in the present study, the 
reduced sample size and the absence of survival 
data are limitations to these analyses.
Final ly, i t  is important to explain the 
dichotomization of the pattern of invasion grades 
in low-invasive OSCCs (grades 1, 2 or 3) and 
high-invasive OSCCs (grade 4). This cut-off was 
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used by Søland, et al.23 (2008), which found a 
worst prognostic outcome for patients with tumors 
showing a grade 4 pattern of invasion (marked and 
widespread cellular dissociation). Also regarding 
this classification, the fact that the number of 
high-invasive OCCCs (13 samples) was almost the 
double of low-invasive OSCCs (7 samples) should be 
considered a limitation of the study. Nevertheless, 
is noteworthy that the sample was composed of 
tumors removed by means of total surgical resection 
(and not by incisional biopsies). Therefore, since the 
whole tumor could be evaluated, the probability 
to identify areas showing marked and widespread 
cellular dissociation (grade 4 pattern of invasion) 
is supposed to be higher.
CONCLUSION
The reduced E-cadherin expression at the IF 
and its association with histological invasiveness 
suggest that this protein is a noteworthy EMT 
marker in OSCC. These findings reinforce the 
relevance of E-cadherin loss as a marker of EMT 
during OSCC progression because the IF has been 
identified as the region chiefly responsible for its 
behavior. Although vimentin was also detected as 
an EMT marker, its expression was neither limited 
to the IF nor related to histological invasiveness.
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